Rare diseases
Investigational molecules
Locations
1 Caspian Point, Wales, Caspian Way, CF10 4DQ, United Kingdom
Biodexa Limited is engaged in clinical research focused on familial adenomatous polyposis, a hereditary condition associated with the development of numerous colorectal polyps and elevated cancer risk. Its trial activity centers on therapeutic strategies intended to address disease progression in this rare gastrointestinal disorder.
The sponsor’s research interest lies in treatment approaches for patients with FAP, reflecting a focus on conditions where long-term disease control and reduction of malignant transformation are central clinical goals.
Biodexa Limited runs clinical trials in conditions such as Adenomatous polyposis coli, among others.
Clinical trials run by this sponsor – those enrolling participants first.
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
